Biological assessment
Sponsors
University Hospital, Bordeaux, Centre Hospitalier Universitaire Dijon, University Hospital, Toulouse
Conditions
Ampullary AdenocarcinomaAutoimmune Hemolytic AnemiaColon or Upper Rectum AdenocarcinomaDepressionDiabete Type 1Prolonged AnticoagulationStrokeVenous Thromboembolic Disease
Phase 2
Phase 3
Investigate the Efficacy of Chemotherapy in Patients With Positive ctDNA After Surgery and Adjuvant Chemotherapy for a Stage III Colorectal Cancer
Not yet recruitingNCT06197425
Start: 2024-01-31End: 2030-01-31Target: 1660Updated: 2024-01-09
PRODIGE 98 : Randomized, Multicenter Phase 3 Trial of Adjuvant Chemotherapy With Modified FOLFIRINOX Versus Capecitabine or Gemcitabine in Patients With Resected Ampullary Adenocarcinoma
RecruitingNCT06813976
Start: 2025-07-02End: 2033-07-31Target: 294Updated: 2025-07-11
Unknown Phase
Mobile Technologies and Post-stroke Depression
CompletedNCT04043052
Start: 2020-09-09End: 2025-03-23Updated: 2025-07-20
Post-Stroke Secondary Prevention With Digital Monitoring
RecruitingNCT06837311
Start: 2025-03-25End: 2028-03-25Target: 388Updated: 2025-07-21
Eating Disturbances in Patients With Type 1 Diabetes Initiating Insulin Therapy
Active, not recruitingNCT07151924
Start: 2025-09-04End: 2027-02-28Target: 100Updated: 2025-09-24